These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 32267784)

  • 1. Filling the Regulatory Gap: Potential Role of Institutional Review Boards in Promoting Consideration of Sex as a Biological Variable.
    Duffy KA; Ziolek TA; Epperson CN
    J Womens Health (Larchmt); 2020 Jun; 29(6):868-875. PubMed ID: 32267784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inclusion of sex and gender in biomedical research: survey of clinical research proposed at the University of Pennsylvania.
    Freeman A; Stanko P; Berkowitz LN; Parnell N; Zuppe A; Bale TL; Ziolek T; Epperson CN
    Biol Sex Differ; 2017; 8():22. PubMed ID: 28649317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex as a Biological Variable: A 5-Year Progress Report and Call to Action.
    Arnegard ME; Whitten LA; Hunter C; Clayton JA
    J Womens Health (Larchmt); 2020 Jun; 29(6):858-864. PubMed ID: 31971851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applying the new SABV (sex as a biological variable) policy to research and clinical care.
    Clayton JA
    Physiol Behav; 2018 Apr; 187():2-5. PubMed ID: 28823546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of warning letters issued to institutional review boards by the United States Food and Drug Administration.
    Bramstedt KA; Kassimatis K
    Clin Invest Med; 2004 Dec; 27(6):316-23. PubMed ID: 15675112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reporting and misreporting of sex differences in the biological sciences.
    Garcia-Sifuentes Y; Maney DL
    Elife; 2021 Nov; 10():. PubMed ID: 34726154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studying both sexes: a guiding principle for biomedicine.
    Clayton JA
    FASEB J; 2016 Feb; 30(2):519-24. PubMed ID: 26514164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Integration of Sex and Gender Considerations Into Biomedical Research: Lessons From International Funding Agencies.
    White J; Tannenbaum C; Klinge I; Schiebinger L; Clayton J
    J Clin Endocrinol Metab; 2021 Sep; 106(10):3034-3048. PubMed ID: 34137862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomedical Researchers' Perceptions of the NIH's Sex as a Biological Variable Policy for Animal Research: Results from a U.S. National Survey.
    Waltz M; Saylor KW; Fisher JA; Walker RL
    J Womens Health (Larchmt); 2021 Oct; 30(10):1395-1405. PubMed ID: 33834877
    [No Abstract]   [Full Text] [Related]  

  • 11. Breaking the camel's back: multicenter clinical trials and local institutional review boards.
    Burman WJ; Reves RR; Cohn DL; Schooley RT
    Ann Intern Med; 2001 Jan; 134(2):152-7. PubMed ID: 11177319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex and the Lab: An Alcohol-Focused Commentary on the NIH Initiative to Balance Sex in Cell and Animal Studies.
    Guizzetti M; Davies DL; Egli M; Finn DA; Molina P; Regunathan S; Robinson DL; Sohrabji F
    Alcohol Clin Exp Res; 2016 Jun; 40(6):1182-91. PubMed ID: 27154003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the National Institutes of Health's Sex as a Biological Variable Policy: Conflicting Accounts from the Front Lines of Animal Research.
    Waltz M; Fisher JA; Lyerly AD; Walker RL
    J Womens Health (Larchmt); 2021 Mar; 30(3):348-354. PubMed ID: 33211575
    [No Abstract]   [Full Text] [Related]  

  • 14. Implementation of the NIH Sex-Inclusion Policy: Attitudes and Opinions of Study Section Members.
    Woitowich NC; Woodruff TK
    J Womens Health (Larchmt); 2019 Jan; 28(1):9-16. PubMed ID: 30539677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transitioning to the National Institutes of Health single institutional review board model: Piloting the use of the Streamlined, Multi-site, Accelerated Resources for Trials IRB Reliance.
    Vardeny O; Hernandez AF; Cohen LW; Franklin A; Baqai M; Palmer S; Bierer BE; Cobb N
    Clin Trials; 2019 Jun; 16(3):290-296. PubMed ID: 30866676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of warning letters issued to clinical investigators and institutional review boards by the United States Food and Drug Administration.
    Gogtay NJ; Doshi BM; Kannan S; Thatte U
    Indian J Med Ethics; 2011; 8(4):211-4. PubMed ID: 22106658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stakeholder Reflections on Implementing the National Institutes of Health's Policy on Single Institutional Review Boards.
    Corneli A; McKenna K; Hanlen-Rosado E; Calvert SB; Mah E; Rosenfeld SJ
    Ethics Hum Res; 2023; 45(5):15-26. PubMed ID: 37777977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimal-risk waiver of informed consent and exception from informed consent (Final Rule) studies at institutional review boards nationwide.
    Ernst AA; Weiss SJ; Nick TG; Iserson K; Biros MH
    Acad Emerg Med; 2005 Nov; 12(11):1134-7. PubMed ID: 16264084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond racial and ethnic analyses in clinical research: a proposed model for Institutional Review Boards.
    Eckstein L
    Food Drug Law J; 2011; 66(2):243-63, ii-iii. PubMed ID: 24505842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating IACUCs: Previous Research and Future Directions.
    Budda ML; Pritt SL
    J Am Assoc Lab Anim Sci; 2020 Nov; 59(6):656-664. PubMed ID: 32928341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.